INS and sarcopenia: Overall, these findings reveal that while both conditions involve endocrine dysregulation, sarcopenia is more dependent on insulin signaling and the imbalance of related metabolic networks, whereas SO primarily manifests as disruptions in hormonal signaling and metabolic pathways due to abnormal adipose tissue.